ALGS Competitors & Alternatives
Compare Aligos Therapeutics Inc with similar stocks in the same industry
Biotechnology
ALGS
Main Stock$4.82
Tradestie Score
49
Market Cap
$71.53M
Revenue Growth
27.8%
Analyst Upside
+986.6%
Top Competitors
223 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ACHV
Achieve Life Sciences, Inc.
|
$6.42
|
$158.43M | - | 59 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$20.08
|
$154.27M | - | 60 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.05
|
$133.50M | - | 63 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$5.38
|
$114.01M | - | 63 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$21.46
|
$110.20M | - | 57 | Compare |
|
ALXO
ALX Oncology Holdings Inc. Common Stock
|
$1.11
|
$96.93M | - | 67 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$2.91
|
$84.52M | - | 42 | Compare |
|
PMVP
PMV Pharmaceuticals, Inc
|
$1.27
|
$72.07M | - | 49 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$7.93
|
$67.94M | - | 60 | Compare |
|
PASG
Passage Bio, Inc. Common Stock
|
$3.63
|
$25.84M | - | 58 | Compare |
More ALGS Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2836)
223 stocks in this industry